Plasma and Urine Levels of Glycosaminoglycans in Patients with Systemic Sclerosis and Their Relationship to Selected Interleukins and Marker of Early Kidney Injury.
chondroitin/dermatan sulfates
glycosaminoglycans
heparan sulfates/heparin
hyaluronic acid
interleukin 17
interleukin 18
keratan sulfates
systemic sclerosis
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
27 Oct 2022
27 Oct 2022
Historique:
received:
23
09
2022
revised:
15
10
2022
accepted:
26
10
2022
entrez:
11
11
2022
pubmed:
12
11
2022
medline:
12
11
2022
Statut:
epublish
Résumé
Systemic sclerosis (SSc) is a chronic connective tissue disease characterized by immune system dysfunction, vasculopathy, and progressive fibrosis of the skin and internal organs, resulting from excessive accumulation of extracellular matrix (ECM) elements, including collagen and proteoglycans (PGs). An uncontrolled PG proliferation, caused by disturbances in their metabolism in tissues, is most likely reflected in the quantitative changes of their components, i.e., glycosaminoglycans (GAGs), in body fluids. Therefore, the aim of this study was to quantify the different types of GAGs in the blood and urine of systemic sclerosis patients. Chondroitin/dermatan sulfates (CS/DS) and heparan sulfates/heparin (HS/H) were quantified by hexuronic acid assay and electrophoretic fractionation, while hyaluronic acid (HA) and keratan sulfates were evaluated using ELISA tests. In turn, individual urinary GAGs were determined using the Blyscan™ Sulfated Glycosaminoglycan Assay Kit. Our results showed that the plasma concentrations of CS/DS, HS/H, HA, and KS in systemic sclerosis patients were significantly higher compared with those in healthy subjects. In the case of urine measurements, we have found that in SSc patients, CS/DC concentrations were significantly higher, while HA concentrations were significantly lower compared with the values observed in the urine of healthy subjects. Importantly, the found by us correlations between plasma keratan sulfate levels and both the duration of the disease and the severity of skin lesions, as expressed by the Rodnan scale, seems to suggest this GAG as a potential marker in assessing disease progression and activity. In addition, a level of urinary excretion of all types of GAGs due to their high positive correlation with uACR, may be a valuable complementary test in the diagnosis of early renal dysfunction in the course of SSc.
Identifiants
pubmed: 36362582
pii: jcm11216354
doi: 10.3390/jcm11216354
pmc: PMC9656736
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Medical University of Silesia
ID : PCN-1-053/N/1/I
Références
Biochem Biophys Res Commun. 2015 Mar 13;458(3):639-643
pubmed: 25684189
Biomed Res Int. 2019 Jan 23;2019:4569826
pubmed: 30809542
Br J Dermatol. 1992 Jan;126(1):29-34
pubmed: 1536759
Clin Chim Acta. 2014 Jun 10;433:20-7
pubmed: 24607326
Biomarkers. 2019 May;24(3):249-254
pubmed: 30457356
Br J Dermatol. 2004 Mar;150(3):469-76
pubmed: 15030329
J Cutan Pathol. 2005 Oct;32(9):612-5
pubmed: 16176298
Ann Rheum Dis. 1985 Sep;44(9):614-20
pubmed: 3876080
Rheumatol Int. 2019 Jul;39(7):1135-1143
pubmed: 31073660
Front Physiol. 2018 Aug 24;9:1177
pubmed: 30197602
Biomed Res Int. 2020 Apr 21;2020:6416514
pubmed: 32382564
Front Immunol. 2018 Oct 22;9:2385
pubmed: 30405606
Scand J Rheumatol. 2022 Mar;51(2):120-127
pubmed: 34169793
Acta Derm Venereol. 1971;51(6):401-6
pubmed: 4109419
Physiol Rev. 2011 Jan;91(1):221-64
pubmed: 21248167
J Invest Dermatol. 1972 Mar;58(3):129-32
pubmed: 4259052
Am J Respir Cell Mol Biol. 2004 Dec;31(6):619-25
pubmed: 15308504
Front Immunol. 2019 Sep 13;10:2025
pubmed: 31572353
Nat Rev Nephrol. 2019 Feb;15(2):87-108
pubmed: 30607032
Clin Transl Immunology. 2019 Apr 06;8(4):e1045
pubmed: 30997045
Acta Derm Venereol. 1986;66(5):409-13
pubmed: 2431578
Acta Derm Venereol. 1994 May;74(3):179-82
pubmed: 7915457
Br J Dermatol. 1991 May;124(5):423-8
pubmed: 2039717
Redox Biol. 2019 Jul;25:101122
pubmed: 30737171
Scand J Rheumatol. 1992;21(1):5-9
pubmed: 1570489
Br J Dermatol. 1997 Jan;136(1):47-53
pubmed: 9039294
Nephrology (Carlton). 2007 Feb;12(1):53-61
pubmed: 17295661
Presse Med. 2014 Oct;43(10 Pt 2):e305-14
pubmed: 25174767
Dermatologica. 1975;150(6):334-45
pubmed: 127727
J Scleroderma Relat Disord. 2018 Feb;3(1):43-52
pubmed: 35382123
Ann Rheum Dis. 2007 Jul;66(7):966-9
pubmed: 17234649
Autoimmun Rev. 2012 Sep;11(11):827-35
pubmed: 22406224
Kidney Int. 2003 Mar;63(3):809-25
pubmed: 12631062
Cytokine. 2018 Jun;106:80-88
pubmed: 29111086
Ann Rheum Dis. 2017 Aug;76(8):1327-1339
pubmed: 27941129
Dermatology. 1997;194(4):329-33
pubmed: 9252752
Ann Rheum Dis. 2013 Nov;72(11):1747-55
pubmed: 24092682
Ann Intern Med. 2013 Jun 4;158(11):825-30
pubmed: 23732715